Accessing literature to support your interpretation of FibroScan scores - with the MyFibroScan Application
The MyFibroScan Application assists FibroScan operators and physicians in interpreting their FibroScan examination results.
Download the app, create a free account, and you will be prompted to provide your CAP™ and VCTE™ scores from the FibroScan examination. The application gives users the option to then choose from a large selection of etiologies and publications.
After providing your VCTE and CAP scores, the MyFibroScan app will then provide users with a graphical representation of their FibroScan scores along with a display of the threshold values for fibrosis and steatosis, displayed as F1-F4 and S1-S4 respectively, based on the publications you select.
The app does not replace physicians and is not intended to diagnose. It provides users with a graphical representation of their FibroScan scores, based on current published literature for the etiology chosen.
Revolutionizing the Assessment of Active Fibrotic-NASH
What is FAST?
FAST is a FibroScan based probability score to help identify patients with active fibrotic NASH.
Designed for patients with suspicion of having NAFLD:
- FAST combines two physical biomarkers, liver stiffness by VCTE and liver fat by CAP, together with a circulating biomarker, AST, into a single score.
- FAST components are readily accessible in point of care, efficiently reducing your reliance on invasive examinations and costly lab tests.
- The FAST output is a probability of active fibrotic-NASH that can be easily interpreted by a healthcare provider.
FAST combines your FibroScan examination results with an easily accessible blood biomarker
to help identify patients with active fibrotic-NASH.
Download The App
Gain free access to:
- FAST score calculator
- Selected and curated selection for articles with threshold values for steatosis and fibrosis
- Graphical representation of patient exam scores
- A free BMI calculator
- Easy access to the Echosens Clinical Library, with over 2,000 peer reviewed publications on liver disease and guidelines
- As the FAST score cutoff increases, the screen failure rates and number of biopsies are reduced. At the same time, this higher cutoff is associated with an increase in missed cases. For this reason, the healthcare provider will determine what FAST score will warrant intervention based on their overall patient assessment.
- Results and thresholds provided by the MyFibroScan App are based on the library of scientific publications related to the selected etiology.
- Depending on the selected etiology, a list of publications is made available for each biomarker (CAP dB/M & stiffness E in kPa).
- The result is a representation of the fibrosis and steatosis stage corresponding to entered biomarkers values according to selected publications.
- Information displayed by the interpretation guides must be interpreted by a healthcare provider.